EPIVX | OANIX | EPIVX / OANIX | |
Total Expense Ratio | 1.73 | 0.81 | 214% |
Annual Report Gross Expense Ratio | 1.73 | 0.81 | 214% |
Fund Existence | 15 years | 9 years | - |
Gain YTD | 22.311 | 23.546 | 95% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 250000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 14.4B | 1% |
Annual Yield % from dividends | 1.48 | 2.29 | 65% |
Returns for 1 year | 24.27 | 21.08 | 115% |
Returns for 3 years | 45.69 | 41.85 | 109% |
Returns for 5 years | 65.76 | 68.54 | 96% |
Returns for 10 years | 90.87 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWT | 59.44 | 0.69 | +1.17% |
iShares MSCI Taiwan ETF | |||
FLLA | 22.12 | 0.22 | +1.03% |
Franklin FTSE Latin America ETF | |||
BJUN | 43.99 | 0.10 | +0.24% |
Innovator U.S. Equity Buffer ETF™ - June | |||
LFSC | 24.66 | N/A | N/A |
F/m Emerald Life Sciences Innovation ETF | |||
HMOP | 38.32 | -0.04 | -0.10% |
Hartford Municipal Opportunities ETF |